FREDERICK, Md., Jan. 7, 2013 /PRNewswire/ -- BioElectronics Corporation (OTCPK: BIEL), maker of consumer medical electronics, announced today that it has begun product distribution with Emergy Products SA in Greece and Cyprus of its ActiPatch® Musculoskeletal Pain Relief, Allay Menstrual Pain Relief and RecoveryRx Postoperative and Wound Care Therapy brands. Emergy Products is a hospital, medical clinic and a wholesale over-the-counter pharmacy supplier.
Emergy Products distributes a wide variety of hospital equipment for such leading US companies such as Ellman International, Elliquence and Dr. Langer in Germany. Emergy also distributes Hylaronic acid for plastic surgeons as well as over-the-counter products such as Liquid Ice Ice Mask.
“Our team in Greece and Cyprus is very excited to add BioElectronics’ innovative product line to our existing line of market leading medical products”, said Peter Milios,Managing Directorof Emergy Products SA. “After having tested the ActiPatch® and Allay products on members of our own team, we are now firmly confident the products will be our best sellers and we are anxious to promote to doctors, pharmacist and most importantly patients.
“We are pleased to add experienced and successful distributors to our network to develop our brands and bring pain relief products to markets worldwide”, said Ben Fichter, Marketing Manager.
For more information about Emergy Products, please visit www.emergyproducts.gr. To view the product websites, please visit www.myactipatch.gr for ActiPatch® and www.myallay.gr for Allay.
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay Menstrual Cycle Pain Therapy, and RecoveryRx for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides cost-effective home care to reduce soft tissue pain and accelerate healing that is 5x better than OTC drugs and 100% safer. For more information, please visit www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation
